SEC INSIDER TRANSACTIONS

STERIS plc (STE) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

STE · STERIS plc

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 48 filings · fetched 2026-11-13T20:00:25Z

Recent reported activity

0purchase rows on this page

4sale rows on this page

84matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-11Filed 2026-11-12	Burton Karen LOfficer · Sr. Vice Pres., CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F3	M Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,880D	0	Direct	Form 4 ↗0001628280-26-073444
2026-11-11Filed 2026-11-12	Burton Karen LOfficer · Sr. Vice Pres., CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F1, F2	S Sale (market/private)Ordinary Shares · Non-derivative	5,880D	255.62	Direct	Form 4 ↗0001628280-26-073444
2026-11-11Filed 2026-11-12	Burton Karen LOfficer · Sr. Vice Pres., CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3 This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References:	M Exercise / conversionOrdinary Shares · Non-derivative	5,880A	147.05	Direct	Form 4 ↗0001628280-26-073444
2026-11-10Filed 2026-11-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F3	M Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,893D	0	Direct	Form 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F2	S Sale (market/private)Ordinary Shares · Non-derivative	1,665D	253.9	Direct	Form 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F1	S Sale (market/private)Ordinary Shares · Non-derivative	3,228D	252.87	Direct	Form 4 ↗0001628280-26-073442
2026-11-10Filed 2026-11-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $252.66 to $253.43 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 Price reflects a weighted average sale price for multiple transactions ranging from $253.69 to $254.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 This option to purchase 4,893 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,893 ordinary shares for $114.74 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References:	M Exercise / conversionOrdinary Shares · Non-derivative	4,893A	114.74	Direct	Form 4 ↗0001628280-26-073442
2026-10-01Filed 2026-10-05	Burton Karen LOfficer · Sr. Vice Pres., CFO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 228 shares were withheld from the 783 restricted shares that vested on October 1, 2026. These 228 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 783 ordinary shares were awarded to Ms. Burton on October 1, 2025. These vested shares were valued at the NYSE closing market price on October 1, 2026. F2 As of October 2, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. References: F1, F2	F WithholdingOrdinary Shares · Non-derivative	228D	0	Direct	Form 4 ↗0001628280-26-064926
2026-08-12Filed 2026-08-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 These nonqualified stock options are fully vested and are exercisable immediately. F3 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F5	M Exercise / conversionDirector Stock Option (right to buy) · Derivative	4,058D	0	Direct	Form 4 ↗0001628280-26-056270
2026-08-12Filed 2026-08-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 These nonqualified stock options are fully vested and are exercisable immediately. F3 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F1	S Sale (market/private)Ordinary Shares · Non-derivative	4,058D	235.78	Direct	Form 4 ↗0001628280-26-056270
2026-08-12Filed 2026-08-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 These nonqualified stock options are fully vested and are exercisable immediately. F3 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References:	M Exercise / conversionOrdinary Shares · Non-derivative	4,058A	86.23	Direct	Form 4 ↗0001628280-26-056270
2026-08-10Filed 2026-08-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 These nonqualified stock options are fully vested and are exercisable immediately. F3 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F3, F4	A Award / grantCareer Restricted Stock Units · Derivative	1,229A	0	Direct	Form 4 ↗0001628280-26-056270
2026-08-10Filed 2026-08-12	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 These nonqualified stock options are fully vested and are exercisable immediately. F3 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F2	A Award / grantDirector Stock Option (right to buy) · Derivative	1,099A	0	Direct	Form 4 ↗0001628280-26-056270
2026-08-10Filed 2026-08-12	Shapiro LouisDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1, F2	A Award / grantCareer Restricted Stock Units · Derivative	1,025A	0	Direct	Form 4 ↗0001628280-26-056267
2026-08-10Filed 2026-08-12	Shah Nirav RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F2, F3	A Award / grantCareer Restricted Stock Units · Derivative	512A	0	Direct	Form 4 ↗0001628280-26-056265
2026-08-10Filed 2026-08-12	Shah Nirav RDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1	A Award / grantDirector Stock Option (right to buy) · Derivative	1,506A	0	Direct	Form 4 ↗0001628280-26-056265
2026-08-10Filed 2026-08-12	Martin Paul EdwardDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F2, F3	A Award / grantCareer Restricted Stock Units · Derivative	512A	0	Direct	Form 4 ↗0001628280-26-056264
2026-08-10Filed 2026-08-12	Martin Paul EdwardDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1	A Award / grantDirector Stock Option (right to buy) · Derivative	1,506A	0	Direct	Form 4 ↗0001628280-26-056264
2026-08-10Filed 2026-08-12	HOLLAND CHRISTOPHER SDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1, F2	A Award / grantCareer Restricted Stock Units · Derivative	1,025A	0	Direct	Form 4 ↗0001628280-26-056262
2026-08-10Filed 2026-08-12	FELDMANN CYNTHIA LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F2, F3	A Award / grantCareer Restricted Stock Units · Derivative	512A	0	Direct	Form 4 ↗0001628280-26-056261
2026-08-10Filed 2026-08-12	FELDMANN CYNTHIA LDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1	A Award / grantDirector Stock Option (right to buy) · Derivative	1,506A	0	Direct	Form 4 ↗0001628280-26-056261
2026-08-10Filed 2026-08-12	Boulud PierreDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1, F2	A Award / grantCareer Restricted Stock Units · Derivative	1,025A	0	Direct	Form 4 ↗0001628280-26-056259
2026-08-10Filed 2026-08-12	Alegria Esther M.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F2, F3	A Award / grantCareer Restricted Stock Units · Derivative	512A	0	Direct	Form 4 ↗0001628280-26-056257
2026-08-10Filed 2026-08-12	Alegria Esther M.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 These nonqualified stock options are fully vested and are exercisable immediately. F2 Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. References: F1	A Award / grantDirector Stock Option (right to buy) · Derivative	1,506A	0	Direct	Form 4 ↗0001628280-26-056257
2026-07-01Filed 2026-07-02	Sohi MohsenDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Net - Cashless Stock Option Exercise - Options to purchase 1,837 shares were surrendered to the Company for payment of the option price. Options surrendered were valued based on the Company stock closing market price on the NYSE on the day on which the Net - Cashless Stock Option Exercise occurred. F2 This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. References: F2	M Exercise / conversionDirector Stock Option (right to buy) · Derivative	3,781D	0	Direct	Form 4 ↗0001628280-26-046946

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.